Incyte | Рыночная Капитализация

Market Capitalization Изменить Дата
Acadia Pharmaceuticals USD 5.14B 1.73B 2023-12
Agios Pharmaceuticals USD 1.25B 135M 2023-12
Alnylam Pharmaceuticals USD 24.02B 1.88B 2023-12
Amgen USD 154.14B 10.38B 2023-12
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Biogen USD 37.5B 274M 2023-12
BioMarin Pharmaceutical USD 18.16B 1.51B 2023-12
Bluebird Bio USD 325M 25M 2023-09
Bristol-Myers Squibb USD 104.4B 16.85B 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Exelixis USD 7.46B 503M 2023-12
Gilead Sciences USD 100.94B 7.57B 2023-12
Incyte USD 12.89B 1.18B 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
Lumos Pharma USD 26M 1000K 2023-09
Merck USD 314.33B 38.07B 2024-03
Moderna USD 40.08B 2.16B 2024-03
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Novartis CHF 193.29B 20.5B 2023-12
Pfizer USD 155.51B 7.05B 2024-03
PTC Therapeutics USD 2.22B 145M 2024-03
Regeneron Pharmaceuticals USD 106.74B 11.05B 2024-03
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Ultragenyx Pharmaceutical USD 3.77B 153M 2024-03
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03



Incyte Рыночная Капитализация - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Apr 2024.